OpenLegislation

Division 1.2.6 Quantities of animal tissues or derivatives required to produce one unit of the medical device

United Kingdom

Original text. Later amendments are not shown.

The manufacturer must evaluate the quantity of raw tissues or derivatives of animal origin required to produce a single unit of the medical device. The manufacturer must assess whether the production process has the potential to concentrate levels of TSE infectious agents present in the animal starting tissues or derivatives.

Notes on Division 1.2

Textual amendments

F1

Words in Annex 1 s. 1.2 substituted (11.8.2021) by The Medical Devices (Amendment) (EU Exit) Regulations 2021 (S.I. 2021/873), reg. 1(1), Sch. 2 para. 15(a)